These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16321566

  • 1. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
    Dasgupta S, Tripathi PK, Qin H, Bhattacharya-Chatterjee M, Valentino J, Chatterjee SK.
    Oral Oncol; 2006 Mar; 42(3):306-16. PubMed ID: 16321566
    [Abstract] [Full Text] [Related]

  • 2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [Abstract] [Full Text] [Related]

  • 3. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
    Malhotra PS, Malekfzali A, Bonner RF, Juhn S, Van Waes C, Chen Z.
    Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
    [Abstract] [Full Text] [Related]

  • 4. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S, Ambrosch P, Cordes C, Görögh T, Schreiber S, Häsler R.
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R, Hulett K, Bicciato S, Di Bello C, Petruzzelli GJ, Lingen MW.
    Cancer Res; 2003 Feb 01; 63(3):555-9. PubMed ID: 12566295
    [Abstract] [Full Text] [Related]

  • 6. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA, Neel HB, Strome SE, Roche P.
    Head Neck; 2003 Jun 01; 25(6):457-63. PubMed ID: 12784237
    [Abstract] [Full Text] [Related]

  • 7. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
    Smith IM, Mithani SK, Liu C, Chang SS, Begum S, Dhara M, Westra W, Sidranksy D, Califano JA.
    Arch Otolaryngol Head Neck Surg; 2009 May 01; 135(5):487-95. PubMed ID: 19451471
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of RAD17 in head and neck cancer.
    Zhao M, Begum S, Ha PK, Westra W, Califano J.
    Head Neck; 2008 Jan 01; 30(1):35-42. PubMed ID: 17657792
    [Abstract] [Full Text] [Related]

  • 9. Molecular assay to detect metastatic head and neck squamous cell carcinoma.
    Becker MT, Shores CG, Yu KK, Yarbrough WG.
    Arch Otolaryngol Head Neck Surg; 2004 Jan 01; 130(1):21-7. PubMed ID: 14732763
    [Abstract] [Full Text] [Related]

  • 10. Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck.
    Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC, Yu TH.
    Anticancer Res; 1999 Jan 01; 19(6B):5037-42. PubMed ID: 10697507
    [Abstract] [Full Text] [Related]

  • 11. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.
    J Pathol; 2008 Mar 01; 214(4):489-97. PubMed ID: 18213732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
    Lee KD, Lee HH, Joo HB, Lee HS, Yu TH, Chang HK, Jeon CH, Park JW.
    Anticancer Res; 2006 Mar 01; 26(2B):1513-8. PubMed ID: 16619566
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS.
    Clin Cancer Res; 2008 Feb 15; 14(4):1002-14. PubMed ID: 18281532
    [Abstract] [Full Text] [Related]

  • 16. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
    Yarbrough WG, Whigham A, Brown B, Roach M, Slebos R.
    Int J Radiat Oncol Biol Phys; 2007 Feb 15; 69(2 Suppl):S98-101. PubMed ID: 17848307
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M, Secades P, Rodrigo JP, Cabanillas R, Herrero A, Suarez C, Chiara MD.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.
    J Pathol; 2009 Mar 01; 217(4):516-23. PubMed ID: 18991334
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K, Hirata S, Irie A, Senju S, Ikuta Y, Yokomine K, Harao M, Inoue M, Tsunoda T, Nakatsuru S, Nakagawa H, Nakamura Y, Baba H, Nishimura Y.
    Clin Cancer Res; 2008 Oct 15; 14(20):6487-95. PubMed ID: 18927288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.